Bridgewater, NJ, United States of America

Mathieu Barrague


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Mathieu Barrague

Introduction

Mathieu Barrague is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceuticals through his innovative research and development efforts. His work focuses on the creation of novel compounds with therapeutic applications.

Latest Patents

Barrague holds a patent for "6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof." This invention pertains to the 6-cycloamino-3-(pyridin-4-yl)imidazo[I,2-b]pyridazine derivatives, which correspond to a specific general formula. The patent also details the preparative methods and therapeutic uses of these compounds, showcasing Barrague's commitment to advancing medical science.

Career Highlights

Barrague is currently employed at Sanofi, a leading global healthcare company. His role involves extensive research and development, contributing to the advancement of innovative therapeutic solutions. His work has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Throughout his career, Barrague has collaborated with esteemed colleagues, including Antonio Almario Garcia and Philippe Burnier. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Mathieu Barrague's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts highlight his importance as an inventor. His work continues to impact the industry positively, paving the way for future advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…